Schwarting G A, Marcus D M, Metaxas M
Vox Sang. 1977;32(5):257-61. doi: 10.1111/j.1423-0410.1977.tb00640.x.
A human antibody which preferentially agglutinates p erythrocytes is inhibited specifically by the glycolipid sialosylparagloboside, NeuNAc (alpha,2 leads to 3)Gal(beta,1 leads t0 4)GlcNAc(beta,1 leads to 3)Gal(beta,1 leads to 4)Glc-Cer and forms a precipitin band with this compound in agarose gel. Erythrocytes treated with neuraminidase are no longer agglutinated by this antibody, but the agglutination is not affected by papain treatment. Sialosylparagloboside is not a biosynthetic precursor of any of the P antigens, but it contains the lacto-N-neotetraose structure which is also present in the P1 glycolipid.
一种优先凝集P血型红细胞的人抗体被糖脂唾液酸副球蛋白、NeuNAc(α2→3)Gal(β1→4)GlcNAc(β1→3)Gal(β1→4)Glc-Cer特异性抑制,并在琼脂糖凝胶中与该化合物形成沉淀带。用神经氨酸酶处理的红细胞不再被该抗体凝集,但凝集不受木瓜蛋白酶处理的影响。唾液酸副球蛋白不是任何一种P抗原的生物合成前体,但它含有乳糖-N-新四糖结构,该结构也存在于P1糖脂中。